Colorectal Cancer

References

Nangia-Makker P, Hogan V et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002 Dec 18;94(24):1854-62.

Neugut AI, Murray TI et al. Cholecystectomy as a risk factor for colorectal adenomatous polyps and carcinoma. Cancer. 1991 Oct 1;68(7):1644-7.

Neuzil J, Weber T et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 2001 Feb;15(2):403-15.

Neuzil J. Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer. 2003 Nov 17;89(10):1822-6.

Newberne PM, Locniskar M. Roles of micronutrients in cancer prevention: recent evidence from the laboratory. Prog Clin Biol Res . 1990;346:119-34.

O'Brien MJ, Winawer SJ et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990 Feb;98(2):371-9.

O'Neil BH, Goldberg RM. Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived. Expert Opin Investig Drugs. 2003 Dec;12(12):1939-49.

Ohwada S, Ikeya T et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer. 2004 Mar 8;90(5):1003-10.

Okulczyk B, Piotrowski Z et al. Evaluation of K-RAS gene in colorectal cancer. Folia Histochem Cytobiol. 2003;41(2):97-100.

Oshima M, Dinchuk JE. et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996 Nov 29;87(5):803-9.

Otsuka S, Inagaki M et al. [Radiofrequency ablation therapy combined with intrahepatic arterial infusion chemotherapy for liver metastasis of colorectal cancer]. Gan To Kagaku Ryoho. 2003 Oct;30(11):1598-601.

Palmqvist R, Engaras B et al. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study. Dis Colon Rectum. 2003 Nov;46(11):1538-44.

Pares A, Planas R et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998 Apr;28(4):615-21.

Pawlik TM, Izzo F et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003 Nov;10(9):1059-69.

Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997 Oct;113(4):1146-58.

Peng G, Dixon DA. et al. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog. 2006 May;45(5):309-19.

Perkins S, Verschoyle RD et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):535-40.

Peters U, Chatterjee N et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):315-20.

Pienta KJ, Naik H et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995 Mar 1;87(5):348-53.

Pierre F, Tache S et al. Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis. 2003;24(10):1683-90.

Pisters KM, Newman RA et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol. 2001 Mar 15;19(6):1830-8.

Platz EA, Giovannucci E et al. Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev. 1997 Sep;6(9):661-70.

Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta. 2005 Nov 25;1756(2):83-96.

Pricolo VE, Finkelstein SD et al. Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg. 1997 Apr;132(4):371-4.

Provenzale D, Kowdley KV et al. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology. 1995 Oct;109(4):1188-96.

Psathakis D, Wedemeyer N et al. Blood selenium and glutathione peroxidase status in patients with colorectal cancer. Dis Colon Rectum. 1998 Mar;41(3):328-35.

Pufulete M, Al Ghnaniem R et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology. 2003 May;124(5):1240-8.

Rao S, Cunningham D. et al. Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer. J Clin Oncol. 2004 Oct 1;22(19):3950-7.

Reddy BS, Rao CV. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors. J Environ Pathol Toxicol Oncol. 2002;21(2):155-64.

Reddy S, Aggarwal BB. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 1994 Mar 14;341(1):19-22.

Reddy BS, Sharma C et al. Metabolic epidemiology of colon cancer: effect of dietary fiber on fecal mutagens and bile acids in healthy subjects. Cancer Res. 1987 Jan 15;47(2):644-8.

Reeves MJ, Newcomb PA et al. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):955-60.

Reynolds JL, Akhter J et al. Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function? Eur J Surg Oncol. 1997 Jun;23(3):224-7.

Rigas B, Goldman IS et al. Altered eicosanoid levels in human colon cancer 1. J Lab Clin Med. 1993 Nov;122(5):518-23.

Robey RW, Steadman K et al. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res. 2004 Feb 15;64(4):1242-6.

Rocklin RE, Greineder DK et al. Histamine-induced suppressor factor (HSF): further studies on the nature of the stimulus and the cell which produces it. Cell Immunol. 1979 May;44(2):404-15.

Rozen P, Fireman Z et al. Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer 1158. Gut. 1989 May;30(5):650-5.

Rozen P, Lubin F et al. Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients. Cancer. 2001 Feb 15;91(4):833-40.

Rumi G, Jr., Szabo I et al. Decrease in serum levels of vitamin A and zeaxanthin in patients with colorectal polyp. Eur J Gastroenterol Hepatol. 1999 Mar;11(3):305-8.

Russo A, Franceschi S et al. Body size and colorectal-cancer risk 1. Int J Cancer. 1998 Oct 5;78(2):161-5.

Russo MW, Murray SC et al. Plasma selenium levels and the risk of colorectal adenomas. Nutr Cancer. 1997;28(2):125-9.

Salucci M, Stivala LA et al. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Br J Cancer. 2002 May 20;86(10):1645-51.

Sandler RS, Halabi S et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003 Mar 6;348(10):883-90.

Satia-Abouta J, Galanko JA, et al. Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):747-54.

Schneider Y, Vincent F et al. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 2000 Sep 29;158(1):85-91.

Schoen RE, Tangen CM, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 1999 Jul 7;91(13):1147-54.

Sharma RA, McLelland HR et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001 Jul;7(7):1894-900.

Sheehan KM, Sheahan K et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA. 1999 Oct 6;282(13):1254-7.

Shibuya K, Mathers CD et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer. 2002 Dec 26;2(1):37.

Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct;56(8):365-79.

Singh J, Hamid R et al. Dietary fat and colon cancer: Modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 1997;57(2):253-8.

Singh J, Hamid R et al. Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis. 1998 Jun;19(6):985-9.

Singh SV. Impact of garlic organosulfides on p21(H-ras) processing. J Nutr. 2001;131(3S):1046S-1048S.

Skrzypczak-Jankun E, Zhou K et al. Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int J Mol Med. 2003 Jul;12(1):17-24.

Smith-Barbaro P, Hanson D et al. Carcinogen binding to various types of dietary fiber. J Natl Cancer Inst. 1981 Aug;67(2):495-7.

Stadler J, Stern HS et al. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids. Gut. 1988 Oct;29(10):1326-31.

Stangl R, Altendorf-Hofmann A et al. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994 Jun 4;343(8910):1405-10.

Steinbach G, Morotomi M et al. Calcium reduces the increased fecal 1,2-sn-diacylglycerol content in intestinal bypass patients: a possible mechanism for altering colonic hyperproliferation. Cancer Res. 1994 Mar 1;54(5):1216-9.

Stierum R, Burgemeister R et al. Functional food ingredients against colorectal cancer. An example project integrating functional genomics, nutrition and health. Nutr Metab Cardiovasc Dis. 2001 Aug;11(4 Suppl):94-8.

Stoeltzing O, Liu W et al. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis. Ann Surg Oncol. 2003 Aug;10(7):722-33.

Stoner GD, Budd GT et al. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. Adv Exp Med Biol. 1999;470:45-53.

Su CC, Chen GW et al. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res. 2006 Mar;26(2A):1281-8.

Sun Y. p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog. 2006 Jun;45(6):409-15.

Suzuki K, Bruce WR. Increase by deoxycholic acid of the colonic nuclear damage induced by known carcinogens in C57BL/6J mice. J Natl Cancer Inst. 1986 Jun;76(6):1129-32.

Szende B, Raso E et al. [A new benzoquinone-containing antimetastatic product]. Orv Hetil. 1998 Nov 29;139(48):2893-7.

Tajmir-Riahi HA, Neault JF et al. DNA adducts with chlorophyll and chlorophyllin as antimutagenic agents: synthesis, stability, and structural features. Methods Mol Biol. 2004;274:159-71.

Takahashi Y, Tucker SL et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg. 1997 May;132(5):541-6.

Takashima S, Kinami Y et al. [Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku] Gan To Kagaku Ryoho. 1988 Aug;15(8):2229-36.

Takeda A, Shimada H et al. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]. Gan To Kagaku Ryoho. 1999 Dec;26(14):2189-94.

Tanaka S, Haruma K et al. Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study. Hiroshima J Med Sci. 2004 Dec;53(3-4):39-45.

Tanaka S, Haruma K et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr. 2006 Mar;136(3 Suppl):821S-826S.

Tang NH, Chen YL et al. Cooperative inhibitory effects of antisense oligonucleotide of cell adhesion molecules and cimetidine on cancer cell adhesion. World J Gastroenterol. 2004 Jan;10(1):62-6.

Tavani A, Fioretti F et al. Pilot study--cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial. Cancer. 1998 Jun 1;82(11):2296-7.

Terry P, Baron JA et al. Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer. 2002;43(1):39-46.

Thoma C, Green TJ et al. Citrus pectin and oligofructose improve folate status and lower serum total homocysteine in rats. Int J Vitam Nutr Res. 2003 Nov;73(6):403-9.

Thun MJ, Namboodiri MM, et al. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593-6.

Tournigand C, Andre T et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004 Jan 15;22(2):229-37.

Traverso G, Shuber A et al. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet. 2002 Feb 2;359(9304):403-4.

Tseng M, Murray SC et al. Micronutrients and the risk of colorectal adenomas. Am J Epidemiol. 1996 Dec 1;144(11):1005-14.

Tsujii M, Kawano S et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998 May 29;93(5):705-16.

Uchida A, Fukata H. Role of NK cell cytotoxic factor against fresh human tumors. Nat Immun. 1993 Jul;12(4-5):267-78.

van Gorkom BA, Karrenbeld A et al. Calcium or resistant starch does not affect colonic epithelial cell proliferation throughout the colon in adenoma patients: a randomized controlled trial. Nutr Cancer. 2002;43(1):31-8.

Vegan Society 2003. Essential Fatty Acids. http://www.vegansociety.com/html/food/nutrition/e_fatty_acids.php. Accessed June 23, 2006.

vivi-Green C, Polak-Charcon S et al. Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition. Oncol Res. 2000;12(2):83-95.

Vogelstein B, Fearon ER et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525-32.

Wallace K, Byers T et al. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):464-7.

Walle T, Hsieh F. et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004 Dec;32(12):1377-82.

Wang JY, Hsieh JS et al. High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients. Int J Cancer. 2003 Nov 10;107(3):387-93.

Wargovich MJ, Isbell G et al. Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma. Gastroenterology. 1992 Jul;103(1):92-7.

Watson P, Lin KM et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998 Jul 15;83(2):259-66.

Weber T, Lu M et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 2002 Mar;8(3):863-9.

Weir HK, Thun MJ et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control 471. J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99.

Welfare MR, Cooper J et al. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England 474. Carcinogenesis. 1997 Jul;18(7):1351-4.

Whelan RL, Horvath KD et al. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum. 1999 Feb;42(2):212-7.

Wilson LC, Baek SJ et al. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int J Cancer. 2003 Jul 20;105(6):747-53.

Winawer SJ, St John J et al. Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68(4):505-13.

Winawer SJ, Shike M. Dietary factors in colorectal cancer and their possible effects on earlier stages of hyperproliferation and adenoma formation 473. J Natl Cancer Inst. 1992 Jan 15;84(2):74-5.

Winawer SJ, Zauber AG et al. Prevention of Colorectal Cancer by Colonoscopic Polypectomy. N Engl J Med. 1993 Dec 30;329(27):1977-81.

Yachida S, Fukushima N et al. Alpha-fetoprotein-producing carcinoma of the colon: report of a case and review of the literature. Dis Colon Rectum. 2003 Jun;46(6):826-31.

Yamamoto Y, Yin MJ et al. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem. 1999 Sep 17;274(38):27307-14.

Yarbro JW, Page DL et al. American Joint Committee on Cancer prognostic factors consensus conference. Cancer. 1999 Dec 1;86(11):2436-46.

Yoshimatsu K, Ishibashi K et al. [Effect of cimetidine with chemotherapy on stage IV colorectal cancer]. Gan To Kagaku Ryoho. 2003 Oct;30(11):1794-7.

Zaniboni A, Torri V et al. Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey. Tumori. 2005 Sep;91(5):383-7.

Zeng Z, Cohen AM et al. Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer. 1992 Aug 15;70(4):737-40.

Zhang SM, Moore SC et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol. 2006 Jan 15;163(2):108-15.

Zhong SS, Zhang ZS et al. [Study of angiogenesis in human colorectal carcinoma and its modulation by p53 and K-ras gene]. Zhonghua Nei Ke Za Zhi. 2003 Feb;42(2):77-80.

Atkins JN, Jacobs SA. et al. Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program. Clin Colorectal Cancer. 2005 Sep;5(3):181-7.

Baron JA, Cole BF. et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003 Mar 6;348(10):891-9.

Bingham S. The fibre-folate debate in colo-rectal cancer. Proc Nutr Soc. 2006 Feb;65(1):19-23.

Broitman SA, Wilkinson J. et al. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv Exp Med Biol 1996;401:111-30. 1995;401:111-30.

Castagnola P, Giaretti W. Mutant KRAS, chromosomal instability and prognosis in colorectal cancer. Biochim Biophys Acta. 2005 Nov 25;1756(2):115-25.

Castellone MD, Teramoto H. et al. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 2005 Dec 2;310(5753):1504-10.

Chan TA. Prostaglandins and the colon cancer connection. Trends Mol Med. 2006 Apr 28.

Chan TA, Morin PJ. et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A. 1998 Jan 20a;95(2):681-6.

Chan TA, Morin PJ. et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A. 1998 Jan 20b;95(2):681-6.

Collett ED, Davidson LA. et al. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol. 2001 May;280(5):C1066-C1075.

Connelly-Frost A, Poole C. et al. Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):486-93.

Doxey BW, Kuwada SK. et al. Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol. 2005 Jul;3(7):633-41.

Eberhart CE, Coffey RJ. et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994 Oct;107(4):1183-8.

Farkas E. [Fermented wheat germ extract in the supportive therapy of colorectal cancer]. Orv Hetil. 2005 Sep 11a;146(37):1925-31.

Farkas E. [Fermented wheat germ extract in the supportive therapy of colorectal cancer]. Orv Hetil. 2005 Sep 11b;146(37):1925-31.

Finley JW. Bioavailability of selenium from foods. Nutr Rev. 2006 Mar;64(3):146-51.

Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res. 2002 May;22(3):1737-54.

Fujiki H, Suganuma M. et al. Cancer inhibition by green tea. Mutat Res. 1998 Jun 18;402(1-2):307-10.

Garami M, Schuler D. et al. Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients. J Pediatr Hematol Oncol. 2004 Oct;26(10):631-5.

Garcea G, Berry DP. et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):120-5.

Gelb MH, Tamanoi F. et al. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett 1995 May 8;91(2):169-75. 1995;91(2):169-75.

Glinskii OV, Huxley VH. et al. Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia. 2005 May;7(5):522-7.

Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2006 Febb;9(1A):124-6.

Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2006 Feba;9(1A):124-6.

Hanif R, Pittas A. et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol. 1996 Jul 26;52(2):237-45.

He TC, Chan TA. et al. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999 Oct 29a;99(3):335-45.

He TC, Chan TA. et al. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999 Oct 29b;99(3):335-45.

Hidvegi M, Raso E. et al. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. Anticancer Res. 1998 Jula;18(4A):2353-8.

Hidvegi M, Raso E. et al. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. Anticancer Res. 1998 Julb;18(4A):2353-8.

Hidvegi M, Raso E. et al. MSC, a new benzoquinone-containing natural product with antimetastatic effect. Cancer Biother Radiopharm. 1999 Aug;14(4):277-89.

Holla VR, Mann JR. et al. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006 Feb 3;281(5):2676-82.

Ide T, Horii M. et al. Contrasting effects of water-soluble and water-insoluble dietary fibers on bile acid conjugation and taurine metabolism in the rat. Lipids. 1990 Jun;25(6):335-40.

Illmer C, Madlener S. et al. Immunologic and biochemical effects of the fermented wheat germ extract Avemar. Exp Biol Med (Maywood ). 2005 Feb;230(2):144-9.

Ishikawa H, Saeki T. et al. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr. 2006 Mar;136(3 Suppl):816S-20S.

Jakab F, Mayer A. et al. First clinical data of a natural immunomodulator in colorectal cancer. Hepatogastroenterology. 2000 Mar;47(32):393-5.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15a;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15b;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15c;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15d;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15e;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15f;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15g;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15h;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15i;21(4):321-39.

Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med. 2000 Jun 29;342(26):1960-8.

Jiao Y, Wilkinson J. et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006 Apr 1a;40(7):1152-60.

Jiao Y, Wilkinson J. et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006 Apr 1b;40(7):1152-60.

Jubb AM, Hurwitz HI. et al. Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. J Clin Oncol. 2006 Jan 10;24(2):217-27.

Kanazawa M, Mori Y. et al. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol Lett. 2004 Feb 15;91(2-3):229-38.

Kobayashi H, Matsunaga K. et al. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev. 1995 Apr;4(3):275-81.

Kulkarni SD, Tilak JC. et al. Evaluation of the antioxidant activity of wheatgrass (Triticum aestivum L.) as a function of growth under different conditions. Phytother Res. 2006 Mar;20(3):218-27.

Louvet C, de GA. Pemetrexed in advanced colorectal cancer. Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):56-62.

Lyn-Cook BD, Rogers T. et al. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer 1999;35(1):80-6. 1999;35(1):80-6.

Martinez ME, Giovannucci E. et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer. 2006 Apr 13.

Matsunaga K, Morita I. et al. [Restoration of immunologic responsiveness by PSK in tumor-bearing animals]. Gan To Kagaku Ryoho. 1986 Dec;13(12):3468-75.

Matsuura N, Miyamae Y. et al. Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr. 2006 Mar;136(3 Suppl):842S-6S.

Mesa RA. Tipifarnib: farnesyl transferase inhibition at a crossroads. Expert Rev Anticancer Ther. 2006 Mar;6(3):313-9.

Ohwada S, Ikeya T. et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer. 2004 Mar 8;90(5):1003-10.

Oshima M, Dinchuk JE. et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996 Nov 29;87(5):803-9.

Peng G, Dixon DA. et al. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog. 2006 May;45(5):309-19.

Peters U, Chatterjee N. et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006 Feba;15(2):315-20.

Peters U, Chatterjee N. et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006 Febb;15(2):315-20.

Pienta KJ, Naik H. et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995 Mar 1;87(5):348-53.

Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta. 2005 Nov 25;1756(2):83-96.

Rao S, Cunningham D. et al. Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer. J Clin Oncol. 2004 Oct 1;22(19):3950-7.

Sandler RS, Halabi S. et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003 Mar 6;348(10):883-90.

Singh J, Hamid R. et al. Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis. 1998 Jun;19(6):985-9.

Singh SV. Impact of garlic organosulfides on p21(H-ras) processing. J Nutr. 2001;131(3S):1046S-8S.

Smith-Barbaro P, Hanson D. et al. Carcinogen binding to various types of dietary fiber. J Natl Cancer Inst. 1981 Aug;67(2):495-7.

Stoner GD, Budd GT. et al. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. Adv Exp Med Biol. 1999;470:45-53.

Su CC, Chen GW. et al. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res. 2006 Mar;26(2A):1281-8.

Sun Y. p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog. 2006 May 1.

Szende B, Raso E. et al. [A new benzoquinone-containing antimetastatic product]. Orv Hetil. 1998 Nov 29;139(48):2893-7.

Tanaka S, Haruma K. et al. Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study. Hiroshima J Med Sci. 2004 Dec;53(3-4):39-45.

Tanaka S, Haruma K. et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr. 2006 Mar;136(3 Suppl):821S-6S.

Tsujii M, Kawano S. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998 May 29;93(5):705-16.

vivi-Green C, Polak-Charcon S. et al. Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition. Oncol Res. 2000;12(2):83-95.

Walle T, Hsieh F. et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004 Dec;32(12):1377-82.

Yamamoto Y, Yin MJ. et al. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem. 1999 Sep 17;274(38):27307-14.

Zaniboni A, Torri V. et al. Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey. Tumori. 2005 Sep;91(5):383-7.

Zhang SM, Moore SC. et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol. 2006 Jan 15;163(2):108-15.